|

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

RECRUITINGN/ASponsored by Rabin Medical Center
Actively Recruiting
PhaseN/A
SponsorRabin Medical Center
Started2023-12-20
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05992363

Summary

Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* patient with malignant ureteral obstruction

Exclusion Criteria:

* ureteral obstruction of other causes
* Language comprehension or other limitation in giving informed consent

Conditions6

CancerHydronephrosis; Obstruction, UreterMalignancyRenal FailureUreter ObstructionUreter Stricture

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.